There are many great features in Samsung's One UI 8.5 beta, but only one that every other Android skin needs to copy.

The new preferred stock offering, SATA, strengthens Strive’s capital options as it expands its bitcoin focused strategy.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Strive Pharmacy's expansion into ...

Creighton has benefited from balanced scoring to win two of its first three games of the season. With six players averaging at least nine points per game, the Bluejays set out to continue their strong ...

Strive provided historical financial statements and unaudited pro forma combined financial information for the merger. Additionally, Strive raised $160 million through an upsized initial public ...

Strive Asset Management (ASST) saw its stock price shift this week, giving investors a chance to revisit its position within the financial sector. Some short-term volatility follows shifting sentiment ...

DALLAS, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: ASST) (“Strive” or the “Company”), the first Bitcoin treasury company amplified exclusively with perpetual preferred equity, today ...

Bitcoin surged past $105,000 on renewed investor confidence, fueled by the US government’s temporary shutdown resolution, growing Fed rate cut bets, and mounting institutional inflows. Among the ...

The Windows Start menu is getting its first major redesign since 2021 and will be rolled out to everyone with the November 11 Patch Tuesday update. The Start menu is now scrollable, so you can move ...

Additionally, Strive has filed a prospectus for the potential resale of up to 1.28 billion shares of its Class A common stock by certain selling securityholders, noting that the company will not ...

Strive (ASST) intends to conduct an initial public offering registered under the Securities Act of 1933, as amended of 1,250,000 shares of Strive’s Variable Rate Series A Perpetual Preferred Stock.

SAN FRANCISCO, CA—Administering low-dose alteplase directly into the artery prior to PCI in patients with STEMI and a large thrombus burden fails to lower the risk of a range of outcomes, including ...